Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Stud...

Por Mounier, Nicolas, El Gnaoui, Taoufik, Tilly, Hervé, Canioni, Danièle, Sebban, Catherine, Casasnovas, René-Olivier, Delarue, Richard, Sonet, Anne, Beaussart, Pauline, Petrella, Tony, Castaigne, Sylvie, Bologna, Serge, Salles, Gilles, Rahmouni, Alain, Gaulard, Philippe, Haioun, Corinne
Publicado em 2013

Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study

Por Lazarovici, Julien, Dartigues, Peggy, Brice, Pauline, Obéric, Lucie, Gaillard, Isabelle, Hunault-Berger, Mathilde, Broussais-Guillaumot, Florence, Gyan, Emmanuel, Bologna, Serge, Nicolas-Virelizier, Emmanuelle, Touati, Mohamed, Casasnovas, Olivier, Delarue, Richard, Orsini-Piocelle, Frédérique, Stamatoullas, Aspasia, Gabarre, Jean, Fornecker, Luc-Matthieu, Gastinne, Thomas, Peyrade, Fréderic, Roland, Virginie, Bachy, Emmanuel, André, Marc, Mounier, Nicolas, Fermé, Christophe
Publicado no Haematologica (2015)

Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma

Por Maurer, Matthew J., Jais, Jean-Philippe, Ghesquières, Hervé, Witzig, Thomas E., Hong, Fangxin, Haioun, Corinne, Thompson, Carrie A., Thieblemont, Catherine, Micallef, Ivana N., Porrata, Luis F., Ribrag, Vincent, Nowakowski, Gregorz S., Casanovas, Olivier, Bologna, Serge, Morschhauser, Franck, Morrison, Vicki A., Peterson, Bruce A., Macon, William R., Copie-Bergman, Christiane, Feldman, Andrew L., Syrbu, Sergei I., Kurtin, Paul J., Gascoyne, Randy D., Li, Hailun, Allmer, Cristine, Kahl, Brad S., Ansell, Stephen M., Slager, Susan L., Link, Brian K., Salles, Gilles, Habermann, Thomas M., Tilly, Hervé, Cerhan, James R.
Publicado no Am J Hematol (2015)